HMM SOME ONE I TEND TO AGREE SELL AT J S BUY IN AND THEN BUY BACK IN AT HIS SELL PP AND JS AND SUPPORTERS MAY HAVE JUST GOTTEN PLAYED ONLY AND OLD BUGGERS VIEW
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025